(Stroke. 1996;27:1118-1123.)
© 1996 American Heart Association, Inc.
Articles |
From the Clinical Research Initiative in Heart Failure, Institute of Biomedical and Life Sciences, and the Department of Medicine and Therapeutics (A.F.D.), Western Infirmary, University of Glasgow (UK).
Correspondence to Dr S.M. Arribas, Clinical Research Initiative in Heart Failure, Institute of Biomedical and Life Sciences, West Medical Bldg, University of Glasgow, Glasgow G12 8QQ, UK. E-mail s.arribas@biomed.gla.ac.uk.
| Abstract |
|---|
|
|
|---|
Methods VSMC orientation was determined with laser-scanning confocal microscopy and computer-assisted image processing in basilar arteries stained with 5(6)-carboxyfluorescein (wavelengths: excitation, 488; emission, 515) or propidium iodide (excitation, 529; emission, 550). Measurements of wall morphology and functional responses to serotonin and KCl were assessed with wire myography.
Results In the WKY basilar arteries, VSMCs were uniformly oriented perpendicular to the longitudinal axis of the vessel, whereas in the SHRSP there were localized foci of VSMC geometric disorganization, with a significant deviation from 90°. The SHRSP basilar arteries also showed structural remodeling and reduced contractile responses to serotonin and KCl. Perindopril treatment normalized blood pressure, prevented wall morphology alterations, and improved function but had no effect on VSMC disorganization.
Conclusions This is the first demonstration of lesions of VSMC geometric disorganization in a cerebral artery from a stroke-prone genetically hypertensive rat strain. These structural abnormalities are independent of blood pressure. Their functional sequel may play a role in the pathogenesis of stroke in this model.
Key Words: basilar artery computer-assisted image processing hypertension muscle, smooth rats
| Introduction |
|---|
|
|
|---|
Established hypertension is associated with alterations in vascular structure that are due to vascular hypertrophy or eutrophic remodeling. This phenomenon is conventionally described in terms of the average overall dimensions of the vessel wall6 7 but not by the detailed arrangement of the cells. LSCM provides a new tool to identify in situ cells in small vessels. Either nuclear or extracellular fluorescent dyes have been shown to identify with good resolution the VSMC location and orientation in resistance arteries.8 The aims of the present study were to determine in isolated basilar arteries from SHRSP and their normotensive reference strain WKY (1) the VSMC geometric arrangement in situ, (2) the vascular morphology, and (3) the responses to agonists. The effects of antihypertensive treatment with the angiotensin-converting enzyme inhibitor perindopril on VSMC geometric arrangement, vascular morphology, and function were also examined.
| Materials and Methods |
|---|
|
|
|---|
Drugs and Solutions
All experiments were performed with PSS consisting of (mmol/L)
NaCl 118.4, KCl 4.7, CaCl2 2.5,
KH2PO4 1.2, MgSO4 1.2,
NaHCO3 25, glucose 11.1, and Na2EDTA 0.023. The
solution was bubbled with 95% O25% CO2 to
give a pH of 7.4 at 37°C. The 125-mmol/L KCl solution was prepared by
substitution of 125 mmol/L KCl for NaCl in PSS. Drugs used were
5(6)-carboxyfluorescein mixed isomers, propidium
iodide, and 5-HT, all purchased from Sigma Chemical Co (UK). Halothane
was purchased from ICI Pharmaceuticals (UK). Stock solutions of the
drugs were made in distilled water and kept frozen. Appropriate
dilutions were made every day.
Confocal Microscopy
The full length of the basilar artery was dissected and
incubated overnight at 4°C in PSS containing 1 mmol/L
5(6)-carboxyfluorescein to stain the extracellular
space. The arteries were then mounted on a slide and viewed in the
presence of the dye. An Odyssey LSCM (Noran Instruments) was used to
obtain stacks of 1-µm optical sections of the regions of interest
(x40 water immersion objective, numerical aperture 0.75, Zeiss;
argon-ion 488-nm line with a 515-nm long-pass barrier filter).
Metamorph software (Universal Imaging Corp) was used for the image
acquisition and processing. From each stack, three images corresponding
to outer, middle, and inner layers of the media were selected. The
angle of orientation of the VSMC with respect to the longitudinal axis
of the vessel was measured in 6 to 10 cells per layer, and from it the
deviation from 90° was calculated.
To stain the VSMC nuclei, the arteries were fixed with formalin (in 10% saline solution), incubated overnight at 4°C with 10 µmol/L propidium iodide, and washed in PSS for 30 minutes. Stacks of 1-µm optical sections of the regions of interest were taken with the LSCM (x60 oil immersion objective, numerical aperture 1.4, Nikon; argon-ion 529-nm line with a 550-nm LP barrier filter). Metamorph software was used to acquire and process the images and for the 3-D reconstructions.
Wire Myography
Segments of the proximal area of the basilar artery (2 mm in
length) were mounted on a wire myograph (Myo-interface, model
410A). Measurements of the vascular morphology were made with a light
microscope (x40 water immersion objective, with a filar eyepiece;
Zeiss), and the vascular segments were then set to the normalized
effective ID of 0.9l100 as previously
described.10 After a 30-minute equilibration period,
contractile responses to 125 mmol/L KCl (osmotically corrected) and a
concentration-response curve to 5-HT (1 nmol/L to 30 µmol/L) were
studied.
Statistics and Data Analysis
Vascular responses were calculated in active wall tension
(millinewton per millimeter). Sensitivities to 5-HT were determined in
terms of pD2 value (negative logarithm of the concentration
required to produce a half-maximal response:
pD2=-log10 EC50), and
EC50 values were calculated by computer extrapolation from
individual logarithm concentration-response curves.
Results are expressed as mean±SEM, and n denotes the number of animals used in each experiment. Statistical comparisons were made using Student's t test for unpaired experiments, with Bonferroni correction for multiple comparisons. A value of P<.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
|
Vascular Remodeling
Basilar arteries of the SHRSP showed increased wall-lumen
ratio and wall thickness and reduced internal and external diameters,
whereas there was no difference in the cross-sectional area. These
features of vascular remodeling12 were present in the
basilar arteries from both old and young SHRSP. In SHRSP-P,
wall-lumen ratio and wall thickness were reduced when compared with
those in untreated SHRSP (Table
).
|
Responses to Agonists
In the SHRSP arteries, the contractile responses elicited by 125
mmol/L KCl (osmotically corrected) and a concentration-response
curve to 5-HT were significantly attenuated compared with these
responses in WKY arteries. Perindopril treatment partially prevented
this reduction of the contractions (Fig 4
). The pD2
values for 5-HT were similar in the three groups of animals (WKY,
7.1±0.02; SHRSP, 6.6±0.16; SHRSP-P, 6.5±0.05), suggesting that the
sensitivity of the receptors was not affected.
|
| Discussion |
|---|
|
|
|---|
These abnormal foci resembled branching points in which the VSMCs reorient to form the new artery. The ability to obtain serial optical sections with the LSCM allowed a detailed analysis of the foci in the z plane, showing that there were no branches underneath the regions of disorientated VSMCs. Active angiogenesis has been associated with cerebral ischemia in humans.15 It is possible that these localized foci observed in stroke-prone rats in our study could correspond to points of angiogenesis leading to the formation of a new branch.
The lesions of randomly arranged VSMCs were observed in arteries that showed decreased lumen and increased wall-lumen ratio, common features in hypertension. The SHRSP basilar artery also showed reduced external diameter and no change in cross-sectional area, suggesting the existence of remodeling, as observed in small arteries from animal models of genetic hypertension and human essential hypertension.6 Treatment of SHRSP with perindopril normalized blood pressure and prevented the abnormal wall dimensions observed in nontreated SHRSP basilar arteries. This is in agreement with most of the studies both in humans and SHR, which have shown that antihypertensive treatment results in reverse remodeling.6
Altered vascular structure has been proposed to play a role in the enhanced responsiveness observed in resistance16 17 and conduit arteries18 19 in hypertension.20 In the SHRSP basilar artery, we found decreased contractility despite increased wall-lumen ratio. A reduced contractility of vascular smooth muscle in hypertension has also been reported in both systemic and cerebral arteries in the rat. In 1970, Bandick and Sparks21 found an increase in excitability but a decrease in maximum contractile responses of femoral vascular smooth muscle associated with renal hypertension. Five years later, Hansen and Bohr,22 also studying the femoral artery, reported a great reduction in the maximal force development in SHR and mineralocorticoid hypertensive rats. These investigators demonstrated that the decreased contractility was not secondary to the increase in wall tension. Cox23 made similar studies on carotid and tail arteries of rats with mineralocorticoid hypertension of 2- to 12-week duration. Results were variable depending on the artery and duration of hypertension; however, contractility was significantly reduced in tail arteries after 12 weeks of hypertension.
Four studies evaluating the contractility of cerebral arteries in hypertension have been reported. One of these studied mineralocorticoid hypertension and found no difference between the maximal contractile responses to either KCl or serotonin.24 Three other studies25 26 27 dealt with SHR, and all reported reduced maximal force generation to KCl, as we observed in the SHRSP basilar artery. The reduction of the contractions induced by KCl, a nonspecific stimulus, in SHRSP and SHR basilar arteries suggests a decreased vasoconstrictor ability of the smooth muscle cells in the cerebral vasculature of both strains. No satisfactory explanation for the cause of this decrease is evident. Differences between normotensive and hypertensive rats in the biochemical properties of VSMCs could play a role, since it has been demonstrated that the cerebral but not mesenteric vessels from SHR have lower actin and myosin levels compared with WKY.28 29 The present study is the first, to our knowledge, in which a maximal force development of vascular smooth muscle of a cerebral artery of SHRSP has been quantified. Compared with the contractility of control muscle, the reduction in the SHRSP was greater than that of any previously reported reductions in contractility of vascular smooth muscle in hypertension. In that sense, the lesions of disorganized VSMCs might contribute to the impairment of contraction, since the cells in these regions might be less efficient at developing force because of the irregular geometric orientation. This is also suggested by the fact that antihypertensive treatment, which did not have an effect on the occurrence of the lesions, did not restore functional responses completely despite significant prevention of the structural remodeling.
The structural and functional alterations reported in this study may have deleterious consequences in the cerebral circulation, especially during hypertension. It is possible that the lesions of disorganized VSMCs could represent regions of weakness in the arterial architecture and potential points of hemorrhage under conditions of extreme high blood pressure, as has been described in the SHRSP strain.4
In summary, we have described three abnormalities of the basilar artery from SHRSP: (1) remodeling, (2) decreased contractile force of VSMC, and (3) circumscribed lesions in which the arrangement of the VSMCs is in disarray. The first two of these abnormalities have been frequently reported in arteries from hypertensive animals. The circumscribed lesions that we observed with LSCM have not been previously described. These lesions appear to be age- and blood pressureindependent and may represent a genetic phenotype.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received September 26, 1995; revision received February 21, 1996; accepted February 22, 1996.
| References |
|---|
|
|
|---|
2. Phillips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension. 1994;25:131-136.
3.
Hougaku H, Matsumoto M, Kitagawa K, Harada K, Oku N,
Itoh T, Maeda H, Handa N, Kamada T. Silent cerebral infarction
as a form of hypertensive target organ damage in the brain.
Hypertension. 1992;20:816-820.
4. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974;34 and 35(suppl 1):143-153.
5.
Yamori Y, Horie R, Handa H, Sato M, Fukase M.
Pathogenic similarity of strokes in stroke-prone spontaneously
hypertensive rats and humans. Stroke. 1976;7:46-55.
6.
Heagerty AM, Aalkajaer C, Bund SJ, Korsgaard N,
Mulvany MJ. Small artery structure in hypertension: dual
processes of remodeling and growth.
Hypertension. 1993;21:391-397.
7.
Gibbons GH, Dzau VJ. The emerging concept of
vascular remodeling. N Engl J Med. 1994;330:1431-1438.
8. Arribas SM, Daly CJ, Gordon JF, McGrath JC. Confocal myography: applications for the study of resistance arteries. In: Halpern W, Bevan JA, Brayden J, Dusten H, Nelson M, Osol G, eds. The Resistance Arteries: Integration of the Regulatory Pathways. Clifton, NJ: Humana Press; 1994:259-264.
9. Dominiczak AF, McLaren Y, Kusel JR, Ball DL, Goodfriend TL, Bohr DF, Reid JL. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke prone spontaneously hypertensive rats. Am J Hypertens. 1993;6:1003-1008. [Medline] [Order article via Infotrieve]
10.
Mulvany MJ, Halpern W. Contractile properties of
small arterial resistance vessels in spontaneously
hypertensive and normotensive rats. Circ
Res. 1977;41:19-26.
11. Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. J Hypertens. 1995;13:211-218. [Medline] [Order article via Infotrieve]
12.
Baumbach GL, Heistad DD. Remodeling of cerebral
arterioles in chronic hypertension.
Hypertension. 1989;13:968-972.
13. Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology. 1985;9:517-534. [Medline] [Order article via Infotrieve]
14. Carr ND, Faragher EB, Hasleton PS. Quantitative study of intimal longitudinal smooth muscle in human small mesenteric arteries. Acta Anat (Basel). 1988;132:69-73. [Medline] [Order article via Infotrieve]
15. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994;25:1794-1798. [Abstract]
16.
Mulvany MJ, Hansen PK, Aalkajaer C. Direct
evidence that a greater contractility of resistance
vessels in spontaneously hypertensive rats is associated with a
narrower lumen, a thicker media, and a greater number of smooth muscle
cell layers. Circ Res. 1978;43:854-864.
17.
Mulvany MJ, Aalkajaer C, Christensen J. Changes
in noradrenaline sensitivity and morphology of
arterial resistance vessels during development of high
blood pressure in spontaneously hypertensive rats.
Hypertension. 1980;2:664-671.
18. Traub O, Lloyd MC, Webb RC. Long-term effects of antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats. Cardiovasc Drugs Ther. 1995;9:421-429. [Medline] [Order article via Infotrieve]
19. Satoh S, Kreutz R, Wilm C, Ganten D, Pfitzed G. Augmented agonist-induced Ca2+-sensitization of coronary contraction in genetically hypertensive rats. J Clin Invest. 1994;94:1397-1403.
20. Folkow B. `Structural factor' in primary and secondary hypertension. Hypertension. 1990;16:89-101.
21. Bandick NR, Sparks HV. Contractile response of vascular smooth muscle of renal hypertensive rats. Am J Physiol. 1970;219:340-344.
22.
Hansen TR, Bohr DF. Hypertension, transmural
pressure, and vascular smooth muscle response in rats.
Circ Res. 1975;36:590-598.
23.
Cox RH. Time course of arterial wall
changes with DOCA plus salt hypertension in the rat.
Hypertension. 1982;4:27-38.
24.
Soltis EE, Bohr DF. Cerebral vascular
responsiveness in deoxycorticosterone acetate-salt hypertensive
rats. Am J Physiol. 1987;252:H198-H203.
25. Yokota Y, Imaizumi Y, Asano M, Matsuda T, Watanabe M. Endothelium-derived relaxing factor released by 5-HT: distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br J Pharmacol. 1994;113:324-330. [Medline] [Order article via Infotrieve]
26. Mulvany MJ. Role of vascular structure in blood pressure development of the spontaneously hypertensive rat. J Hypertens. 1986;4(suppl 3):S61-S63.
27.
Winquist RJ, Bohr DF. Structural and
functional changes in cerebral arteries from spontaneously hypertensive
rats. Hypertension. 1983;5:292-297.
28. Brayden JE, Halpern W. Biochemical and mechanical correlates in SHR cerebral and mesenteric resistance blood vessels. Physiologist. 1981;24:73. Abstract.
29.
Brayden JE, Halpern W, Brann IR. Biochemical and
mechanical properties of resistance vessels from normotensive and
hypertensive rats. Hypertension. 1983;5:17-25.
This article has been cited by other articles:
![]() |
J. M. Osmond, J. D. Mintz, B. Dalton, and D. W. Stepp Obesity Increases Blood Pressure, Cerebral Vascular Remodeling, and Severity of Stroke in the Zucker Rat Hypertension, February 1, 2009; 53(2): 381 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Lee, G. Zhai, Q. Liu, E. R. Gonzales, K. Yin, P. Yan, C. Y. Hsu, K. D. Vo, and W. Lin Vascular Permeability Precedes Spontaneous Intracerebral Hemorrhage in Stroke-Prone Spontaneously Hypertensive Rats Stroke, December 1, 2007; 38(12): 3289 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Arribas, C. J. Daly, M. C. Gonzalez, and J. C. McGrath Imaging the vascular wall using confocal microscopy J. Physiol., October 1, 2007; 584(1): 5 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Guerrini, L. Sironi, E. Tremoli, M. Cimino, B. Pollo, A. M. Calvio, R. Paoletti, and M. Asdente New Insights Into Brain Damage in Stroke-Prone Rats: A Nuclear Magnetic Imaging Study Stroke, March 1, 2002; 33(3): 825 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zeng, Y. Zhang, J. Mo, Z. Su, R. Huang, and H. A. Kontos Two-Kidney, Two Clip Renovascular Hypertensive Rats Can Be Used as Stroke-prone Rats • Editorial Comment Stroke, August 1, 1998; 29(8): 1708 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Arribas, C. Hillier, C. Gonzalez, S. McGrory, A. F. Dominiczak, and J. C. McGrath Cellular Aspects of Vascular Remodeling in Hypertension Revealed by Confocal Microscopy Hypertension, December 1, 1997; 30(6): 1455 - 1464. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |